Himalee Sabnis

Clinical trials

• AflacLL1901 (CHOA-AML)

  Principal investigator · Terminated · Phase 2

  Emory University

  2020–2022
• Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma

  Principal investigator · Completed · Phase 1

  Emory University

  2018–2023
• Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  Site PI · Recruiting · Phase 1

  St. Jude Children's Research Hospital

  2024–2027
• The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  Site PI · Recruiting · Phase 1, Phase 2

  PedAL BCU, LLC

  2022–2030